| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.600 | None | 0.957 | 1 | 0 | 1993 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.590 | None | 1.000 | 3 | 0 | 1996 | 2019 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.590 | None | 1.000 | 2 | 0 | 1996 | 2019 | ||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
disease | 0.560 | None | 1.000 | 1 | 0 | 2007 | 2018 | ||||||||
|
transforming growth factor alpha | 0.432 | 0.885 | 0.72 |
|
disease | 0.550 | None | 1.000 | 1 | 0 | 1996 | 2014 | ||||||||
|
peroxisome proliferator activated receptor alpha | 0.432 | 0.885 | 3.0E-02 |
|
disease | 0.550 | None | 1.000 | 1 | 0 | 1999 | 2019 | ||||||||
|
insulin like growth factor 2 | 0.390 | 0.885 | 4.4E-02 |
|
disease | 0.540 | None | 1.000 | 1 | 0 | 1988 | 2007 | ||||||||
|
fragile histidine triad diadenosine triphosphatase | 0.444 | 0.846 | 5.7E-03 |
|
disease | 0.530 | None | 1.000 | 1 | 0 | 1998 | 2017 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.520 | None | 1.000 | 1 | 0 | 1993 | 2020 | ||||||||
|
asparagine synthetase (glutamine-hydrolyzing) | 0.595 | 0.692 | 9.4E-06 |
|
disease | 0.510 | None | 1.000 | 1 | 0 | 1976 | 2019 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2019 | ||||||||
|
glypican 3 | 0.466 | 0.808 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2005 | 2020 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2002 | 2017 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 1993 | 2020 | ||||||||
|
hepatocyte nuclear factor 4 alpha | 0.461 | 0.808 | 0.15 |
|
disease | 0.280 | None | 0.889 | 1 | 0 | 2010 | 2019 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
disease | 0.270 | None | 1.000 | 1 | 0 | 1999 | 2019 | ||||||||
|
caspase 3 | 0.351 | 0.923 | 0.10 |
|
disease | 0.270 | None | 1.000 | 1 | 0 | 2007 | 2018 | ||||||||
|
collagen type XVIII alpha 1 chain | 0.449 | 0.808 | 1.7E-10 |
|
disease | 0.240 | None | 1.000 | 1 | 0 | 2004 | 2011 | ||||||||
|
aldo-keto reductase family 1 member B | 0.491 | 0.885 | 2.0E-05 |
|
disease | 0.240 | None | 0.800 | 1 | 0 | 1998 | 2017 | ||||||||
|
microRNA 25 | 0.517 | 0.769 |
|
disease | 0.230 | None | 1.000 | 4 | 0 | 2010 | 2019 | |||||||||
|
microRNA 145 | 0.431 | 0.846 |
|
disease | 0.230 | None | 1.000 | 1 | 0 | 2013 | 2018 | |||||||||
|
serine and arginine rich splicing factor 1 | 0.563 | 0.692 | 0.98 |
|
disease | 0.230 | None | 1.000 | 1 | 0 | 2013 | 2018 | ||||||||
|
proliferating cell nuclear antigen | 0.382 | 0.846 | 0.98 |
|
disease | 0.230 | None | 1.000 | 1 | 0 | 2010 | 2016 | ||||||||
|
cell adhesion molecule 1 | 0.491 | 0.769 | 0.66 |
|
disease | 0.230 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
Fas cell surface death receptor | 0.372 | 0.923 | 0.81 |
|
disease | 0.220 | None | 1.000 | 1 | 0 | 2010 | 2018 |